Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

Stay up to date with John Dudley (Australian, 1931 - 2018) . Discover works for sale, auction results, market data, news and exhibitions on MutualArt.

The Virginian-Pilot: Your source for Virginia breaking news, sports, business, entertainment, weather and traffic ...